, /PRNewswire/ -- , the world's first Lab Insights company, applauds federal efforts to rein in fraudulent billing associated with lab testing. The Telehealth Modernization Act, which is passing through Congress, includes the federal government's latest effort to address laboratory , waste, and abuse. Specifically, it consists of a provision ordering the Office of the Inspector General (OIG) of the U.
S. Department of Health and Human Services to submit to Congress a report by , assessing fraudulent Medicare and Medicaid claims for clinical diagnostic lab tests. "Over 14 billion lab tests are performed yearly, making it the most commonly used medical benefit," said Avalon CEO , MD.
"While the overwhelming majority of providers and labs are honest, it is important that we identify those who abuse this crucial healthcare component to end those abusive practices." In the past few years, the OIG and Justice Department have on telemedicine companies involved in fraudulent billing schemes, some involving genetic testing. This prompted the inclusion of anti- measures in the telehealth legislation.
Avalon prevents abuse of genetic testing through its Genetic Test Management solutions and , a carefully curated group of high-quality genetic testing labs coupled with expert consultative services. With Avalon's comprehensive end-to-end solutions, health plans outsource the management of genetic testing, utilization management, pricing, compliance enforcement, test quality assessment, new .